Protara Therapeutics
Clinical trials sponsored by Protara Therapeutics, explained in plain language.
-
New liquid treatment tested for aggressive bladder cancer
Disease control Recruiting nowThis study is testing whether a liquid treatment called TARA-002 can safely control high-grade bladder cancer that hasn't spread into the muscle wall. Researchers will give the treatment directly into the bladder of 131 adults and monitor them for up to 5 years to see if it preve…
Phase: PHASE2 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
New injection aims to protect livers in patients fed through veins
Disease control Recruiting nowThis study is testing whether choline chloride injections can help prevent or treat liver injury in people with intestinal failure who must get their nutrition through an IV. Researchers will compare two different doses of the injection against a placebo in adolescents and adults…
Phase: PHASE2, PHASE3 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New injection trial offers hope for kids with rare, disfiguring growths
Disease control Recruiting nowThis study is testing an experimental injection called TARA-002 for children with large, fluid-filled growths called lymphatic malformations. The main goal is to see if the treatment is safe and if it can shrink these growths. Children aged 6 months to 18 years may receive up to …
Phase: PHASE2 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC